1.江苏省卫健委重点项目：基于纳米探针的冠心病高危患者早期多模态分子影像诊断研究

2. 国家自然科学基金面上项目（NO:81770231）:泛素化连接酶TRIM38在心肌肥厚中的作用及机制研究，2018/01-2021/12，资助金额55万元，在研，主持

3. 江苏省自然科学基金面上项目（NO:SBK20161436）：TRIM8在心肌肥厚中的作用及机制研究，2016/07-2019/06，资助金额10万元，在研，主持

4．国家自然科学基金面上项目（NO:81270203/H0203）:利用条件性敲除 RBP-J 的心脏祖细胞研究 Notch 信号通路在增强干细胞心脏修复中的作用，2013/01-2016/12，资助金额70万元，结题，主持。

5. 国家自然科学基金青年基金项目（NO:81400219）： SDF-1对心脏干细胞C-kit基因DNA甲基化调控的机制研究 ，2015/01-2018/12，资助金额23.5万元，在研，参加者

6. 国家自然科学基金面上项目（NO:81070083）：缺氧预适应上调SDF-1/CXCR4轴调节的抗凋亡通路改善归巢心脏祖细胞的存活，2011/01-2013/12，资助金额32万元，已经结题，参加者（排名第二）。

7. 国家自然科学基金面上项目（NO:30570743）：磁探针标记自体骨髓间充质干细胞移植治疗急性心肌梗死的核磁共振示踪实验研究,2006/01-2008/12，已经结题，参加者（排名第五）。

8. 江苏省自然科学基金面上项目（NO:SBK20081829）：血红素氧化酶-1涂层支架预防再狭窄实验研究,2008/01-2011/12，资助金额8万元，已经结题，主持。

1.      Chunshu Hao, Zhengri Lu,Yuanyuan Zhao,  Zhong Chen,  Chengxing Shen, Genshan Ma,Lijuan Chen. Overexpression of GATA4 enhances the antiapoptotic effect of exosomes secreted from cardiac colony-forming unitfibroblasts via miRNA221-mediatedtargeting of the PTEN/PI3K/AKT signaling pathway. Stem cell research &therapy. 2020.

2.     Zhengri Lu ,Genshan Ma, Lijuan Chen.Sitagliptin on Carotid Intima-Media Thickness in Type 2 Diabetes MellitusPatients and Anemia: A Subgroup Analysis of the PROLOGUE Study. Mediators of Inflammation Volume 2020, Article ID8143835.

3.  陆政日,马根山,陈立娟.中性粒细胞与淋巴细胞比值与老年急性冠脉综合征患者近期预后的关系.第二军医大学学报(Academic Journal of Second MilitaryMedical University).2019.Vol.40.No.10(1103-1110)

4. 庞思,陈忠,朱孔博,何砚如,Gondo Esther Kema Hawa,章晓国,童嘉毅,马根山,陈立娟.药物涂层球囊治疗急性冠脉综合征的系统评价. 东南大学学报( 医学版) 2018,Feb;37(1):31-34

5.Lijuan Chen, Si Pang, Chunshu Hao, Aiming Xie, Kongbo Zhu, Yanru He,Xiaoguo Zhang, Wenbing Lu,Genshan Ma, and Zhong Chen. Prevention of neointimal formation after angioplasty using tetramethylpyrazine-coated ballooncatheters in a rabbit iliac artery model. Cardiovasc Diagn Ther .2019;9(5):472-480.

6.He Y, Pang S, Huang J, Zhu K, Tong J, Tang Y, Ma G,Chen L. Blockade of RBP-J-Mediated Notch Signaling PathwayExacerbates Cardiac Remodeling after Infarction by Increasing Apoptosis inMice. BioMed Research International, 2018 Jul 3;2018:5207031

7. Lijuan Chen, Jia Huang, Yan-xiaoJi, FanghuaMei, Pi-xiao Wang, Ke-qiong Deng, Xi Jiang, Genshan Ma, Hongliang Li. TripartiteMotif 8 Contributes to Pathological Cardiac Hypertrophy through EnhancingTAK1-dependent Signaling Pathways.Hypertension.2017 ;69(2):249-258(IF=6.857)

8. Chen L, Huang J,Ji Y, Zhang X, Wang P, Deng K, Jiang X, Ma G, Li H. Tripartite Motif 32Prevents Pathological Cardiac Hypertrophy. Clin Sci (Lond). 2016.130(10):813-28 (IF=5.598)

9. Jia Huang, Lijuan Chen, Yuyu Yao, Chengchun Tang, Jiandong Ding, Cong Fu, Hongliang Li, Genshan Ma. Pivotal Role ofRegulator of G-protein Signaling 12 in Pathological Cardiac Hypertrophy. Hypertension. 2016;67:1228-1236( IF=6.294)

10.Yingjie Wang, Lan Zhang, Yongjun Li， Lijuan Chen, Xiaolong Wang ,Wei Guo,Xue Zhang, Gangjian Qin, Sheng-hu He ,Arthur Zimmerman, Yutao Liu,  Il-man Kim, Neal L.Weintraub, Yaoliang Tang. Exosomes/microvesicles frominduced pluripotent stem cells deliver cardioprotective miRNAs and preventcardiomyocyte apoptosis in the ischemic myocardium. International Journal ofCardiology 192 (2015) 61–69(IF=4.036 共同第一作者)

11. Chen L,Phillips MI, Miao HL, Zeng R, Qin G, Kim IM, Weintraub NL, Tang Y. Infraredfluorescent protein 1.4 genetic labeling tracks engrafted cardiac progenitorcells in mouse ischemic hearts. PLoS One 2014;9(10):e107841. (IF=3.234)

12. Chen L, Pan Y, Zhang L, Wang Y, Weintraub N, Tang Y. Two-stepprotocol for isolation and culture of cardiospheres. Methods Mol Biol2013;1036:75-80.

13. LijuanChen, YingjieWang,  Yaohua Pan, Lan Zhang,Chengxing Shen, Gangjian Qin, Muhammad Ashraf, NealWeintraub, Genshan Ma,and Yaoliang Tang. Cardiac progenitor-derived Exosomes protectischemic myocardium from acute ischemia/reperfusion injury. Biochem BiophysRes Commun. 2013 February 15; 431(3): 566–571. (IF=2.297)

14. Chen L,Ashraf M, Wang Y, Zhou M, Zhang J, Qin G, Rubinstein J, Weintraub NL, Tang Y.The role of notch 1 activation in cardiosphere derived cell differentiation.Stem Cells Dev 2012;21(12):2122-9. (IF=3.727)

15. Zhang L, Pan Y, Qin G, Chen L, Chatterjee TK, Weintraub NL,Tang Y. Inhibition of stearoyl-coA desaturase selectively eliminatestumorigenic Nanog-positive cells: improving the safety of iPS celltransplantation to myocardium. Cell Cycle 2014;13(5):762-71. (IF=4.565)

16.Wenbin Lu,Lijuan Chen, YuWang, Yuyu Yao, Cong Fu, Pengfei Zuo, Genshan Ma. Rationaleand design of MANJUSRI trial: A randomized, open-label, active-controlledmulticenter study to evaluate the safety of combined therapy with ticagrelorand warfarin in AF subjects after PCI-eS. Contemporary Clinical Trials 40(2015) 166–171.(IF=1.597)

17. Tang YL, Wang YJ, Chen LJ, Pan YH, Zhang L, Weintraub NL. Cardiac-derived stemcell-based therapy for heart failure: progress and clinical applications. ExpBiol Med (Maywood) 2013;238(3):294-300. (IF=2.165)

18. Tang Y, Wang Y, Chen L, Pan Y, Weintraub N. Cross talkbetween the Notch signaling and noncoding RNA on the fate of stem cells. ProgMol Biol Transl Sci 2012;111:175-93. (IF=3.488)

19. Yan F, Yao Y, Chen L, LiY, Sheng Z, Ma G. Hypoxic preconditioning improves survival of cardiacprogenitor cells: role of stromal cell derived factor-1alpha-CXCR4 axis. PLoSOne 2012;7(7):e37948. (IF=3.234)

20.Jiang YB, Chen LJ, TangYL, MaGS, Shen CX Qi CM, Zhu Q, Yao YY, Liu NF. HO-1 gene overexpression enha ncesthe beneficial effects of superparamagnetic iron oxide labeled bone marrowstromal cells transplantation in swine hearts underwent ischemia/reperfusion:an MRI study. Basic Res Cardiol. 2010 May;105(3):431-42. Epub 2009 Dec24.(IF=5.973)

21.Tang YL,Zhu W, Cheng M, Chen L, Zhang J, SunT, Kishore R, Phillips MI, Losordo DW, Qin G. Hypoxic preconditioning enhancesthe benefit of cardiac progenitor-cell therapy for treatment of myocardialinfarction by inducing CXCR4 expression. Circ.Res. 2009 ;104:1209-1216.(IF=9.214)(with editorial comment titled “Importance of the SDF-1:CXCR4 axis inmyocardial repair”, Penn MS. Circ Res. 2009 104(10):1133-5).

22. Ma GS, Chen LJ,Chen Z, Ding S, Shen CX , Feng,Y.  Biocompatibility of TMP-elutingstents innormal porcine coronary arteries. Biomedicine & Pharmacotherapy. 2008;62(2):125-129.

23. 陈立娟，冯毅，丁澍，沈成兴，陈忠，李璇，马根山. 川芎嗪药物涂层支架预防猪冠状动脉再狭窄的实验研究. 中华心血管病杂志. 200836(9):843-846